Drugs / Seocalcitol
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00051545 | Nov 1999 → Jun 2004 | liver cancer | LEO Pharma | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00051532 | Sep 1999 → May 2004 | liver and intrahepatic bile duct neoplasm | LEO Pharma | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seocalcitol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00051545 ↗ |
| Known as | CB-1089 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1908376 ↗ |
| Known as | EB 1089 | “Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment” NCT00051532 ↗1“Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5 ug) or Placebo” NCT00051545 ↗ |
| Action | Activate | “Vitamin D receptor agonist” CHEMBL1908376 ↗ |
| Modality | Small molecule | — CHEMBL1908376 ↗ |
| Target | VDR | “Vitamin D receptor agonist” CHEMBL1908376 ↗ |